Bruker Corporation Stock Price, News & Analysis (NASDAQ:BRKR)

$33.74 0.41 (1.23 %)
(As of 11/17/2017 04:00 PM ET)
Previous Close$33.33
Today's Range$32.98 - $33.80
52-Week Range$21.03 - $35.16
Volume517,296 shs
Average Volume630,287 shs
Market Capitalization$5.08534 billion
P/E Ratio27.94
Dividend Yield0.49%
Beta1.05

About Bruker Corporation (NASDAQ:BRKR)

Bruker Corporation logoBruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.


Industry, Sector and Symbol:
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: Life Sciences Tools & Services
  • Sector: Computer and Technology
  • Symbol: NASDAQ:BRKR
  • CUSIP: 11679410
  • Web: www.bruker.com
Debt:
  • Debt-to-Equity Ratio: 0.65%
  • Current Ratio: 2.60%
  • Quick Ratio: 1.60%
Price-To-Earnings:
  • Trailing P/E Ratio: 27.94
  • Forward P/E Ratio: 28.35
  • P/E Growth: 2.76
Sales & Book Value:
  • Annual Sales: $1.6113 billion
  • Price / Sales: 3.26
  • Cash Flow: $1.59 per share
  • Price / Cash: 21.26
  • Book Value: $4.76 per share
  • Price / Book: 7.09
Dividend:
  • Annual Dividend: $0.16
  • Dividend Yield: 0.5%
Profitability:
  • Trailing EPS: $0.94
  • Net Income: $153.6 million
  • Net Margins: 8.85%
  • Return on Equity: 25.83%
  • Return on Assets: 10.05%
Misc:
  • Employees: 6,000
  • Outstanding Shares: 155,560,000
 
Frequently Asked Questions for Bruker Corporation (NASDAQ:BRKR)

What is Bruker Corporation's stock symbol?

Bruker Corporation trades on the NASDAQ under the ticker symbol "BRKR."

How often does Bruker Corporation pay dividends? What is the dividend yield for Bruker Corporation?

Bruker Corporation declared a quarterly dividend on Monday, November 13th. Investors of record on Monday, December 4th will be paid a dividend of $0.04 per share on Friday, December 22nd. This represents a $0.16 annualized dividend and a yield of 0.47%. The ex-dividend date of this dividend is Friday, December 1st. View Bruker Corporation's Dividend History.

How will Bruker Corporation's stock buyback program work?

Bruker Corporation declared that its Board of Directors has initiated a stock buyback plan on Sunday, June 4th 2017, which permits the company to repurchase $225,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Shares repurchase plans are generally a sign that the company's board believes its stock is undervalued.

How were Bruker Corporation's earnings last quarter?

Bruker Corporation (NASDAQ:BRKR) announced its quarterly earnings results on Thursday, November, 2nd. The medical research company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.27 by $0.02. The medical research company earned $435.60 million during the quarter, compared to the consensus estimate of $415.45 million. Bruker Corporation had a net margin of 8.85% and a return on equity of 25.83%. Bruker Corporation's quarterly revenue was up 10.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.32 EPS. View Bruker Corporation's Earnings History.

When will Bruker Corporation make its next earnings announcement?

Bruker Corporation is scheduled to release their next quarterly earnings announcement on Monday, February, 12th 2018. View Earnings Estimates for Bruker Corporation.

Where is Bruker Corporation's stock going? Where will Bruker Corporation's stock price be in 2017?

14 analysts have issued twelve-month target prices for Bruker Corporation's stock. Their forecasts range from $24.00 to $34.00. On average, they anticipate Bruker Corporation's stock price to reach $28.90 in the next twelve months. View Analyst Ratings for Bruker Corporation.

What are Wall Street analysts saying about Bruker Corporation stock?

Here are some recent quotes from research analysts about Bruker Corporation stock:

  • 1. According to Zacks Investment Research, "Bruker exited the third quarter on a solid note with better-than-expected earnings and revenue performance. Scientific Instruments segment performed well where growth was driven by strong results within NANO and CALID groups. The company also raised 2017 guidance, which is indicative of brighter prospects. Moving on, the company’s strategic acquisition activity has been encouraging. In this context, the company recently announced the completion of acquisition of Germany-based MERLIN whose products can complement Bruker’s MALDI Biotyper platform. Following its promising third quarter 2017 performance, Bruker has been observed to trade above the broader industry over the past three months. On the flip side, currency fluctuations, competitive landscape and macroeconomic headwinds continue to pose challenges for the company." (11/10/2017)
  • 2. Jefferies Group LLC analysts commented, "4Q16 EPS walloped consensus (+9c / +4c operational), while the initial 2017 EPS outlook bracketed consensus. Commentary pointed to further signs of endmarket stability as EU orders turned positive in 4Q (first time all yr). Net-net, BRKR is managing the P&L better than it ever has, and with end-mkts steadily improving, we like the risk/reward & see room for upside. We modestly raise our '17/18 EPS by +1c/+5c (to $1.08/$1.30)." (2/14/2017)
  • 3. Evercore ISI analysts commented, "Bruker continues to execute well across its business, delivering on impressive GM expansion, while continuing OpEx rationalization and stepping up capital allocation. Thus in terms of what management can control they are doing an excellent job and certainly have delivered much of what shareholders demanded several years ago. That being said end markets remain not fully cooperative, and while EU academic has improved it is off of depressed levels. Given this dynamic core growth remains constrained and in a year where the growth comparable is tough due to tax savings the current outlook for EPS upside is mixed. With shares trading north of 20x we contend that visibility back to 3-5% core growth must improve, and we look for further check points from management in the first part of 2017. We think if bookings momentum continues to accelerate over the next few quarters that will be the signal to get incrementally constructive on shares. Therefore we await additional proof points and in the near-term remain on the sidelines." (2/14/2017)
  • 4. Cantor Fitzgerald analysts commented, "CytoSorbents announced that the company has now received a permanent, dedicated, reimbursement procedure code for CytoSorb in Germany." This is positive news." (12/7/2016)

Who are some of Bruker Corporation's key competitors?

Who are Bruker Corporation's key executives?

Bruker Corporation's management team includes the folowing people:

  • Frank H. Laukien Ph.D., Chairman of the Board, President, Chief Executive Officer (Age 57)
  • Anthony L. Mattacchione, Chief Financial Officer, Senior Vice President (Age 54)
  • Juergen Srega, President of Bruker CALID Group and Bruker Daltonics Division (Age 62)
  • Mark Robert Munch Ph.D., Executive Vice President - President of Bruker Nano Group and Bruker Nano Surfaces Division (Age 55)
  • William A. Linton, Lead Independent Director (Age 69)
  • Joerg C. Laukien, Director (Age 63)
  • Cynthia M. Friend Ph.D., Independent Director (Age 62)
  • Marc A. Kastner Ph.D., Independent Director (Age 71)
  • Richard D. Kniss, Independent Director (Age 76)

Who owns Bruker Corporation stock?

Bruker Corporation's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Boston Partners (1.36%), Victory Capital Management Inc. (1.21%), Russell Investments Group Ltd. (0.97%), Dimensional Fund Advisors LP (0.59%), Wells Fargo & Company MN (0.53%) and First Quadrant L P CA (0.52%). Company insiders that own Bruker Corporation stock include Frank H Laukien, Ingen Chris Van, Joerg C Laukien, Mark Munch, Richard A Packer, Richard Kniss and Wolf-Dieter Emmerich. View Institutional Ownership Trends for Bruker Corporation.

Who sold Bruker Corporation stock? Who is selling Bruker Corporation stock?

Bruker Corporation's stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, Cambiar Investors LLC, Russell Investments Group Ltd., Canada Pension Plan Investment Board, Allianz Asset Management GmbH, California State Teachers Retirement System, Cornerstone Capital Management Holdings LLC. and New York State Common Retirement Fund. Company insiders that have sold Bruker Corporation company stock in the last year include Ingen Chris Van, Mark Munch and Richard Kniss. View Insider Buying and Selling for Bruker Corporation.

Who bought Bruker Corporation stock? Who is buying Bruker Corporation stock?

Bruker Corporation's stock was acquired by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Prudential Financial Inc., Fisher Asset Management LLC, Citadel Advisors LLC, Janus Henderson Group PLC, Palisade Capital Management LLC NJ, Jennison Associates LLC and Point72 Asset Management L.P.. Company insiders that have bought Bruker Corporation stock in the last two years include Frank H Laukien and Richard A Packer. View Insider Buying and Selling for Bruker Corporation.

How do I buy Bruker Corporation stock?

Shares of Bruker Corporation can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bruker Corporation's stock price today?

One share of Bruker Corporation stock can currently be purchased for approximately $33.74.

How big of a company is Bruker Corporation?

Bruker Corporation has a market capitalization of $5.08534 billion and generates $1.6113 billion in revenue each year. The medical research company earns $153.6 million in net income (profit) each year or $0.94 on an earnings per share basis. Bruker Corporation employs 6,000 workers across the globe.

How can I contact Bruker Corporation?

Bruker Corporation's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at investor.relations@bruker.com.


MarketBeat Community Rating for Bruker Corporation (NASDAQ BRKR)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  288 (Vote Outperform)
Underperform Votes:  348 (Vote Underperform)
Total Votes:  636
MarketBeat's community ratings are surveys of what our community members think about Bruker Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Ratings for Bruker Corporation (NASDAQ:BRKR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Sell Ratings, 9 Hold Ratings, 3 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Hold (Score: 2.07)
Consensus Price Target: $28.90 (14.34% downside)
Consensus Price Target History for Bruker Corporation (NASDAQ:BRKR)
Price Target History for Bruker Corporation (NASDAQ:BRKR)
Analysts' Ratings History for Bruker Corporation (NASDAQ:BRKR)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/3/2017Citigroup Inc.Boost Price TargetNeutral$29.00 -> $34.00N/AView Rating Details
11/3/2017Cowen and CompanyReiterated RatingHold$29.00N/AView Rating Details
11/3/2017Bank of America CorporationUpgradeUnderperform -> Neutral$34.00N/AView Rating Details
11/3/2017J P Morgan Chase & CoUpgradeUnderweight -> Neutral$28.00N/AView Rating Details
9/26/2017Goldman Sachs Group, Inc. (The)Reiterated RatingSell -> Sell$24.00LowView Rating Details
7/17/2017Barclays PLCReiterated RatingEqual Weight$26.00 -> $30.00LowView Rating Details
7/12/2017Wells Fargo & CompanyDowngradeMarket Perform -> UnderperformMediumView Rating Details
5/15/2017Jefferies Group LLCReiterated RatingBuy$29.00N/AView Rating Details
5/15/2017Deutsche Bank AGBoost Price TargetHold$25.00 -> $27.00N/AView Rating Details
4/27/2017Cleveland ResearchUpgradeNeutral -> BuyHighView Rating Details
3/27/2017Janney Montgomery ScottDowngradeBuy -> NeutralLowView Rating Details
2/15/2017BTIG ResearchReiterated RatingHoldN/AView Rating Details
2/14/2017Cantor FitzgeraldSet Price TargetBuy$28.00N/AView Rating Details
2/14/2017Evercore ISIBoost Price TargetHold$23.50 -> $26.00N/AView Rating Details
11/10/2016Leerink SwannInitiated CoverageMarket Perform$21.00N/AView Rating Details
8/3/2016Morgan StanleySet Price TargetHold$23.00N/AView Rating Details
8/3/2016MizuhoLower Price TargetNeutral$28.00 -> $23.00N/AView Rating Details
3/14/2016Stifel NicolausBoost Price TargetBuy$25.00 -> $32.00N/AView Rating Details
1/6/2016Avondale PartnersInitiated CoverageMarket Perform$26.00N/AView Rating Details
(Data available from 11/17/2015 forward)

Earnings

Earnings History for Bruker Corporation (NASDAQ:BRKR)
Earnings by Quarter for Bruker Corporation (NASDAQ:BRKR)
Earnings History by Quarter for Bruker Corporation (NASDAQ BRKR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/12/2018$0.48N/AView Earnings Details
11/2/2017Q3 2017$0.27$0.29$415.45 million$435.60 millionViewN/AView Earnings Details
8/3/2017Q2 2017$0.20$0.23$384.75 million$414.90 millionViewN/AView Earnings Details
5/3/2017Q1 2017$0.19$0.19$372.59 million$384.90 millionViewN/AView Earnings Details
2/13/2017Q416$0.37$0.46$464.49 million$470.30 millionViewN/AView Earnings Details
11/2/2016Q316$0.20$0.32$394.14 million$393.90 millionViewN/AView Earnings Details
8/2/2016Q216$0.20$0.20$409.57 million$371.70 millionViewN/AView Earnings Details
5/4/2016Q116$0.15$0.21$360.37 million$375.40 millionViewN/AView Earnings Details
2/10/2016Q415$0.27$0.38$469.98 million$478.20 millionViewN/AView Earnings Details
11/4/2015Q315$0.13$0.19$373.65 million$396.10 millionViewN/AView Earnings Details
8/5/2015Q215$0.17$0.19$391.87 million$396.00 millionViewN/AView Earnings Details
5/6/2015Q115$0.10$0.14$369.80 million$353.50 millionViewN/AView Earnings Details
2/19/2015Q414$0.29$0.30$515.50 million$508.00 millionViewN/AView Earnings Details
11/6/2014Q314$0.15$0.14$436.30 million$419.80 millionViewN/AView Earnings Details
8/6/2014Q214$0.19$0.21$457.90 million$457.40 millionViewN/AView Earnings Details
5/7/2014Q114$0.09$0.11$402.04 million$423.70 millionViewN/AView Earnings Details
2/18/2014Q413$0.22$0.31$452.14 million$552.10 millionViewListenView Earnings Details
11/1/2013Q313$0.22$0.20$452.40 million$439.00 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.14$0.18$426.39 million$454.90 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.14$0.08$416.76 million$393.40 millionViewListenView Earnings Details
2/19/2013Q4 2012$0.24$0.28$483.65 million$517.30 millionViewListenView Earnings Details
11/5/2012Q312$0.15$0.28$421.39 million$447.80 millionViewN/AView Earnings Details
7/31/2012$0.12$0.12ViewN/AView Earnings Details
5/1/2012$0.12$0.14ViewN/AView Earnings Details
2/22/2012$0.29$0.31ViewN/AView Earnings Details
10/27/2011$0.22$0.23ViewN/AView Earnings Details
8/3/2011$0.21$0.20ViewN/AView Earnings Details
4/28/2011$0.15$0.14ViewN/AView Earnings Details
2/23/2011$0.27$0.27ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Bruker Corporation (NASDAQ:BRKR)
2017 EPS Consensus Estimate: $1.11
2018 EPS Consensus Estimate: $1.32
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.18$0.21$0.19
Q2 20173$0.17$0.21$0.19
Q3 20173$0.25$0.30$0.27
Q4 20173$0.42$0.49$0.46
Q1 20183$0.22$0.30$0.25
Q2 20183$0.26$0.32$0.28
Q3 20183$0.32$0.34$0.33
Q4 20183$0.40$0.50$0.45
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Bruker Corporation (NASDAQ:BRKR)
Next Dividend:12/22/2017
Annual Dividend:$0.16
Dividend Yield:0.47%
Payout Ratio:17.02% (Trailing 12 Months of Earnings)
13.45% (Based on This Year's Estimates)
12.03% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Bruker Corporation (NASDAQ:BRKR)

Dividend History by Quarter for Bruker Corporation (NASDAQ BRKR)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/13/2017quarterly$0.040.49%12/1/201712/4/201712/22/2017
8/14/2017quarterly$0.040.57%8/31/20179/5/20179/22/2017
5/15/2017quarterly$0.040.61%6/1/20176/5/20176/23/2017
2/21/2017quarterly$0.040.65%3/6/20173/8/20173/24/2017
11/15/2016quarterly$0.040.69%12/1/201612/5/201612/23/2016
8/9/2016quarterly$0.040.72%9/1/20169/6/20169/23/2016
5/18/2016quarterly$0.040.61%6/2/20166/6/20166/24/2016
2/22/2016Quarterly$0.043/2/20163/4/20163/24/2016
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Bruker Corporation (NASDAQ BRKR)
Insider Ownership Percentage: 35.20%
Institutional Ownership Percentage: 65.47%
Insider Trades by Quarter for Bruker Corporation (NASDAQ:BRKR)
Institutional Ownership by Quarter for Bruker Corporation (NASDAQ:BRKR)
Insider Trades by Quarter for Bruker Corporation (NASDAQ BRKR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/13/2017Mark MunchVPSell21,061$29.97$631,198.17View SEC Filing  
8/10/2017Frank H LaukienCEOBuy2,335$27.39$63,955.65View SEC Filing  
6/14/2017Ingen Chris VanDirectorSell19,900$28.03$557,797.00View SEC Filing  
6/13/2017Richard KnissDirectorSell24,000$28.23$677,520.00View SEC Filing  
6/8/2017Mark MunchVPSell73,724$27.62$2,036,256.88View SEC Filing  
5/19/2017Frank H LaukienCEOBuy3,200$26.13$83,616.00View SEC Filing  
5/18/2017Frank H LaukienCEOBuy73,000$26.22$1,914,060.00View SEC Filing  
5/16/2017Frank H LaukienCEOBuy1,920$25.88$49,689.60View SEC Filing  
3/17/2017Frank H LaukienCEOBuy4,300$23.34$100,362.00View SEC Filing  
3/13/2017Frank H LaukienCEOBuy2,300$23.74$54,602.00View SEC Filing  
12/15/2016Frank H LaukienCEOBuy4,725$21.22$100,264.50View SEC Filing  
12/13/2016Ingen Chris VanDirectorSell20,000$22.29$445,800.00View SEC Filing  
11/25/2016Frank H LaukienCEOBuy2,124$22.90$48,639.60View SEC Filing  
8/10/2016Richard A PackerDirectorBuy10,000$21.97$219,700.00View SEC Filing  
8/5/2016Frank H LaukienCEOBuy4,500$22.17$99,765.00View SEC Filing  
6/14/2016Frank H LaukienCEOBuy4,174$23.95$99,967.30View SEC Filing  
6/6/2016Joerg C LaukienDirectorSell2,000,000$25.65$51,300,000.00View SEC Filing  
5/9/2016Wolf-Dieter EmmerichDirectorSell21,000$27.35$574,350.00View SEC Filing  
6/15/2015Frank H LaukienCEOBuy1,000,000$19.50$19,500,000.00View SEC Filing  
6/11/2015Frank H LaukienCEOBuy5,901$20.31$119,849.31View SEC Filing  
6/11/2015Stephen W FesikDirectorSell15,000$20.48$307,200.00View SEC Filing  
3/17/2015Charles F Wagner JrCFOSell19,000$18.97$360,430.00View SEC Filing  
3/5/2015Richard A PackerDirectorBuy15,000$19.00$285,000.00View SEC Filing  
2/25/2015Frank H LaukienCEOBuy5,271$18.95$99,885.45View SEC Filing  
12/14/2012Frank H LaukienCEOBuy50,000$14.68$734,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Bruker Corporation (NASDAQ:BRKR)
Latest Headlines for Bruker Corporation (NASDAQ BRKR)
Source:
DateHeadline
Bruker Announces Quarterly DividendBruker Announces Quarterly Dividend
finance.yahoo.com - November 14 at 12:27 AM
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bruker Corporation (BRKR)SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bruker Corporation (BRKR)
finance.yahoo.com - November 14 at 12:27 AM
Bruker Corporation Declares Quarterly Dividend of $0.04 (BRKR)Bruker Corporation Declares Quarterly Dividend of $0.04 (BRKR)
www.americanbankingnews.com - November 13 at 1:04 PM
Q3 2018 Earnings Estimate for Bruker Corporation Issued By Jefferies Group (BRKR)Q3 2018 Earnings Estimate for Bruker Corporation Issued By Jefferies Group (BRKR)
www.americanbankingnews.com - November 13 at 7:26 AM
Bruker declares $0.04 dividendBruker declares $0.04 dividend
seekingalpha.com - November 13 at 7:24 AM
Investors Buy Large Volume of Bruker Corporation Put Options (BRKR)Investors Buy Large Volume of Bruker Corporation Put Options (BRKR)
www.americanbankingnews.com - November 12 at 1:56 AM
Zacks Investment Research Downgrades Bruker Corporation (BRKR) to HoldZacks Investment Research Downgrades Bruker Corporation (BRKR) to Hold
www.americanbankingnews.com - November 12 at 12:22 AM
Bruker's NANO Grows Strong, MERLIN Buyout Holds PromiseBruker's NANO Grows Strong, MERLIN Buyout Holds Promise
finance.yahoo.com - November 11 at 12:12 PM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bruker Corporation (BRKR)SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bruker Corporation (BRKR)
finance.yahoo.com - November 10 at 4:17 PM
Glancy Prongay & Murray LLP Commences Investigation on Behalf of Bruker Corporation Investors (BRKR)Glancy Prongay & Murray LLP Commences Investigation on Behalf of Bruker Corporation Investors (BRKR)
finance.yahoo.com - November 10 at 12:38 PM
BRKR INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Bruker Corporation InvestorsBRKR INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Bruker Corporation Investors
finance.yahoo.com - November 10 at 12:38 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bruker Corporation - BRKRSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bruker Corporation - BRKR
finance.yahoo.com - November 10 at 12:38 PM
FY2017 Earnings Estimate for Bruker Corporation Issued By Jefferies Group (BRKR)FY2017 Earnings Estimate for Bruker Corporation Issued By Jefferies Group (BRKR)
www.americanbankingnews.com - November 10 at 8:34 AM
FY2017 EPS Estimates for Bruker Corporation Boosted by Analyst (BRKR)FY2017 EPS Estimates for Bruker Corporation Boosted by Analyst (BRKR)
www.americanbankingnews.com - November 9 at 8:30 AM
Bruker Corporation (BRKR) Upgraded to Buy at Zacks Investment ResearchBruker Corporation (BRKR) Upgraded to Buy at Zacks Investment Research
www.americanbankingnews.com - November 8 at 5:45 PM
Bruker (BRKR) in Focus: Stock Moves 6.5% HigherBruker (BRKR) in Focus: Stock Moves 6.5% Higher
finance.yahoo.com - November 6 at 5:53 PM
Bruker Corporation (BRKR) Expected to Earn Q1 2018 Earnings of $0.23 Per ShareBruker Corporation (BRKR) Expected to Earn Q1 2018 Earnings of $0.23 Per Share
www.americanbankingnews.com - November 6 at 10:40 AM
FY2017 EPS Estimates for Bruker Corporation (BRKR) Increased by AnalystFY2017 EPS Estimates for Bruker Corporation (BRKR) Increased by Analyst
www.americanbankingnews.com - November 6 at 7:14 AM
Bruker Corporation (BRKR) Receives Consensus Recommendation of "Hold" from BrokeragesBruker Corporation (BRKR) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - November 5 at 9:30 PM
Bruker Corporation (BRKR) Upgraded to "Neutral" by J P Morgan Chase & CoBruker Corporation (BRKR) Upgraded to "Neutral" by J P Morgan Chase & Co
www.americanbankingnews.com - November 5 at 7:36 PM
Bruker Corporation (BRKR) Lifted to "Neutral" at Bank of America CorporationBruker Corporation (BRKR) Lifted to "Neutral" at Bank of America Corporation
www.americanbankingnews.com - November 5 at 6:58 PM
Citigroup Inc. Raises Bruker Corporation (BRKR) Price Target to $34.00Citigroup Inc. Raises Bruker Corporation (BRKR) Price Target to $34.00
www.americanbankingnews.com - November 4 at 6:06 PM
Bruker Corporations (BRKR) "Hold" Rating Reaffirmed at Cowen and CompanyBruker Corporation's (BRKR) "Hold" Rating Reaffirmed at Cowen and Company
www.americanbankingnews.com - November 3 at 7:50 PM
Bruker (BRKR) Q3 2017 Results - Earnings Call TranscriptBruker (BRKR) Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 3 at 5:23 PM
Edited Transcript of BRKR earnings conference call or presentation 2-Nov-17 8:30pm GMTEdited Transcript of BRKR earnings conference call or presentation 2-Nov-17 8:30pm GMT
finance.yahoo.com - November 3 at 8:22 AM
Bruker Corporation (BRKR) Posts  Earnings Results, Beats Estimates By $0.02 EPSBruker Corporation (BRKR) Posts Earnings Results, Beats Estimates By $0.02 EPS
www.americanbankingnews.com - November 2 at 9:29 PM
Noteworthy Thursday Option Activity: BRKR, AAC, NWLNoteworthy Thursday Option Activity: BRKR, AAC, NWL
www.thestreet.com - November 2 at 5:26 PM
What Are Analysts Saying About the future of Bruker Corporation’s (BRKR) Business?What Are Analysts Saying About the future of Bruker Corporation’s (BRKR) Business?
finance.yahoo.com - November 2 at 5:26 PM
Bruker Corporation to Host Earnings CallBruker Corporation to Host Earnings Call
finance.yahoo.com - November 2 at 5:26 PM
Bruker Reports Third Quarter 2017 Financial ResultsBruker Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 2 at 5:26 PM
Bruker tops Street 3Q forecastsBruker tops Street 3Q forecasts
finance.yahoo.com - November 2 at 5:26 PM
First Week of BRKR June 2018 Options TradingFirst Week of BRKR June 2018 Options Trading
www.nasdaq.com - October 31 at 5:55 PM
Bruker Corporation (BRKR) vs. Its Peers Financial ContrastBruker Corporation (BRKR) vs. Its Peers Financial Contrast
www.americanbankingnews.com - October 28 at 11:40 AM
$414.24 Million in Sales Expected for Bruker Corporation (BRKR) This Quarter$414.24 Million in Sales Expected for Bruker Corporation (BRKR) This Quarter
www.americanbankingnews.com - October 28 at 8:38 AM
Bruker Corporation (BRKR) Set to Announce Earnings on ThursdayBruker Corporation (BRKR) Set to Announce Earnings on Thursday
www.americanbankingnews.com - October 26 at 2:42 AM
FY2017 Earnings Forecast for Bruker Corporation (BRKR) Issued By Jefferies GroupFY2017 Earnings Forecast for Bruker Corporation (BRKR) Issued By Jefferies Group
www.americanbankingnews.com - October 23 at 4:22 AM
Comparing Bruker Corporation (BRKR) and Accuray (ARAY)Comparing Bruker Corporation (BRKR) and Accuray (ARAY)
www.americanbankingnews.com - October 21 at 4:24 AM
Bruker Announces Date and Time of Third Quarter 2017 Earnings Release and WebcastBruker Announces Date and Time of Third Quarter 2017 Earnings Release and Webcast
finance.yahoo.com - October 16 at 5:30 PM
Contrasting Bruker Corporation (BRKR) & Its CompetitorsContrasting Bruker Corporation (BRKR) & Its Competitors
www.americanbankingnews.com - October 12 at 2:26 AM
Bruker Corporation (BRKR) Given Consensus Rating of "Hold" by AnalystsBruker Corporation (BRKR) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - October 12 at 12:48 AM
Featured Company News - Bruker Introduces Additional Key Products for Diagnosis and Susceptibility Testing of Invasive Fungal DiseasesFeatured Company News - Bruker Introduces Additional Key Products for Diagnosis and Susceptibility Testing of Invasive Fungal Diseases
finance.yahoo.com - October 9 at 5:30 PM
Bruker Introduces Additional Key Products for Diagnosis and Susceptibility Testing of Invasive Fungal Diseases (IFD) into European Clinical Microbiology MarketsBruker Introduces Additional Key Products for Diagnosis and Susceptibility Testing of Invasive Fungal Diseases (IFD) into European Clinical Microbiology Markets
finance.yahoo.com - October 6 at 5:02 PM
Accuray (ARAY) vs. Bruker Corporation (BRKR) Financial ComparisonAccuray (ARAY) vs. Bruker Corporation (BRKR) Financial Comparison
www.americanbankingnews.com - October 5 at 4:50 PM
Electronic Equipment Stocks: What Best Wealth-Builders Now?Electronic Equipment Stocks: What Best Wealth-Builders Now?
seekingalpha.com - October 3 at 4:33 PM
Bruker Corporations (BRKR) Sell Rating Reaffirmed at Goldman Sachs Group, Inc. (The)Bruker Corporation's (BRKR) Sell Rating Reaffirmed at Goldman Sachs Group, Inc. (The)
www.americanbankingnews.com - October 1 at 11:34 PM
Is Bruker Corporation’s (BRKR) ROE Of 22.57% Sustainable?Is Bruker Corporation’s (BRKR) ROE Of 22.57% Sustainable?
finance.yahoo.com - September 30 at 6:20 PM
Bruker Announces Acquisition of MERLIN to Add Selected Antibiotic Resistance and Susceptibility Testing to its MALDI Biotyper® Microbial Identification PlatformBruker Announces Acquisition of MERLIN to Add Selected Antibiotic Resistance and Susceptibility Testing to its MALDI Biotyper® Microbial Identification Platform
finance.yahoo.com - September 26 at 8:20 AM
Bruker Corp. : BRKR-US: Dividend Analysis : September 05th, 2017 (record date) : By the numbers : September 25, 2017Bruker Corp. : BRKR-US: Dividend Analysis : September 05th, 2017 (record date) : By the numbers : September 25, 2017
finance.yahoo.com - September 25 at 8:00 PM
Danaher Corporation (DHR) vs. Bruker Corporation (BRKR) Financial ComparisonDanaher Corporation (DHR) vs. Bruker Corporation (BRKR) Financial Comparison
www.americanbankingnews.com - September 23 at 8:32 PM
 Brokerages Anticipate Bruker Corporation (BRKR) to Post $0.27 EPS Brokerages Anticipate Bruker Corporation (BRKR) to Post $0.27 EPS
www.americanbankingnews.com - September 19 at 4:12 AM

Social Media

Financials

Chart

Bruker Corporation (NASDAQ BRKR) Chart for Friday, November, 17, 2017
Loading chart…

This page was last updated on 11/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.